---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-019610"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2022-10-17T23:59:59+00:00"
generated_at: "2026-06-23T03:14:05.858588+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# KalVista Pharmaceuticals appoints Brian J.G. Pereira as Chairman; Martin Edwards resigns in planned transition

## Summary
- Martin Edwards resigned as Chairman and director effective immediately; departure not due to any disagreement.
- Brian J.G. Pereira appointed Chairman; previously a board member since 2019 and President & CEO of Visterra.
- Annual meeting results: T. Andrew Crockett and Brian J.G. Pereira elected as Class I directors.
- Deloitte & Touche ratified as auditor for FY ending April 30, 2023; advisory say-on-pay approved.

## SEC filing metadata
- accession: 0000950170-22-019610
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2022-10-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000095017022019610/0000950170-22-019610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000095017022019610/kalv-20221013.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-019610
- JSON: https://secwatch.observer/filing/0000950170-22-019610.json
- Plain text: https://secwatch.observer/filing/0000950170-22-019610.txt

## Key facts
- Executive change
  Martin Edwards resigned as Chairman of the Board at KalVista Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chairman of the Board
  source text: On October 13, 2022, Martin Edwards, M.D., announced his resignation from his position as the Chairman of the Board of Directors (the “Board”) and as a Class III director, member of the Compensation Committee of the Board (the “Compensation Committee”) and member of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”) of KalVista Pharmaceuticals, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348911/000095017022019610/0000950170-22-019610-index.htm
- Executive change
  Brian J. G. Pereira was appointed as Chairman of the Board at KalVista Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chairman of the Board
  source text: The Board approved the appointment of Brian J. G. Pereira, M.D., as Chairman of the Board, effective upon Dr. Edwards’ resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348911/000095017022019610/0000950170-22-019610-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.